Abstract: A transdermal delivery system (TDS) having: a carrier layer (cover layer) impermeable to the substances/active ingredients to be delivered, a membrane permeable to the substances/active ingredients to be delivered, a reservoir containing substances/active ingredients to be delivered, the reservoir being provided between the carrier layer and the membrane; and a removable film, wherein the carrier layer and the membrane comprise electrodes such that the electrode(s) of the membrane serve(s) as counterelectrode(s) to the electrode (the electrodes) of the carrier layer, is disclosed.
Abstract: A transdermal delivery system (TDS) having: a carrier layer (cover layer) impermeable to the substances/active ingredients to be delivered; a membrane permeable to the substances/active ingredients to be delivered; a reservoir containing substances/active ingredients to be delivered, the reservoir being provided between the carrier layer and the membrane; and a removable film, wherein each of the carrier layer and the membrane comprise one or more electrodes such that the electrode(s) of the membrane serve(s) as counter electrode(s) to die electrode (the electrodes) of the carrier layer, is disclosed.
Abstract: This invention refers to a transdermal system for release of 5-HT3 receptor antagonists which is characterized in that it contains a composition of a 5-HT3 receptor antagonist as an active agent, tea tree oil, a water-miscible solvent and water.
Abstract: A permeation cell for the in vitro determination of the permeation of pharmaceutical active ingredients through the skin, having a donor chamber (34) and an acceptor chamber (4) that is separable therefrom, a window lying between them for receiving sealingly a skin membrane wherein the acceptor chamber (4) is in the form of a cylindrical vessel that is upright during operation, having a closure (8; 50) at its upper end and a side window opening (6) in the region near its base, and the donor chamber (34) is in the form of a connection piece that joins onto the acceptor chamber radially and can be closed at its outer end. The acceptor chamber (4) is inserted removably into a housing (10), which housing has, in the region of the window opening (6) of the acceptor chamber, a corresponding slightly wider opening (30), and the connection piece forming the donor chamber (34) is screwed removably onto the housing concentrically with the window opening (6).